Adenosine deaminase affects ligand-induced signalling by interacting with cell surface adenosine receptors  by Ciruela, Francisco et al.
FEBS 16637 FEBS Letters 380 (1996) 219 223 
Adenosine deaminase affects ligand-induced signalling by interacting with 
cell surface adenosine receptors 
Francisco Ciruela, Carles Saura, Enric I. Canela, Josefa Mallol, Carmen Lluis, Rafael Franco* 
Departament de Bioquimica i Biologia Molecular, Facultat de Quimica, Universitat de Barcelona, Marti Franquks 1, Barcelona 08028, Catalonia, Spain 
Received 30 October 1995; revised version received 2 January 1996 
Abstract Adenosine deaminase (ADA) is not only a cytosolic 
enzyme but can be found as an ecto-enzyme. At the plasma 
membrane, an adenosine deaminase binding protein (CD26, also 
known as dipeptidylpeptidase IV) has been identified but the 
functional role of this ADMCD26 complex is unclear. Here by 
confocal microscopy, affinity chromatography and coprecipita- 
tion experiments we show that A 1 adenosine receptor (AIR) is a 
second ecto-ADA binding protein. Binding of ADA to AtR in- 
creased its affinity for the ligand thus suggesting that ADA was 
needed for an effective coupling between A~R and heterotrimeric 
G proteins. This was confirmed by the fact that ASA, independ- 
ently of its catalytic behaviour, enhanced the ligand-induced sec- 
ond messenger production via AtR. These findings demonstrate 
that, apart from the cleavage of adenosine, a further role of 
ecto-adenosine deaminase on the cell surface is to facilitate the 
signal transduction via AIR. 
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1. Introduction 
Adenosine, acting through specific receptors on the cell sur- 
face, is capable of exerting multiple physiological actions in a 
variety of cell types [1-3]. All known adenosine receptors are 
heptaspanning macromolecules coupled to heterotrimeric G 
proteins. A~ adenosine receptors (A1R) display two different 
affinity states that depend upon the coupling to heterotrimeric 
G proteins; coupled receptor-G protein complexes display high 
affinity (K d = 0.1-0.2 nM), whereas uncoupled receptors dis- 
play low affinity (K  d = 1-2 nM) [4-6]. 
A~R-mediated signalling depends on the effective concentra- 
tion of extracellular adenosine, whose regulation involves a 
variety of nucleoside transport systems and ecto-nucleotidases 
[7]. Since we discovered adenosine deaminase (ADA, EC 
3.5.4.4) on the surface of hematopoietic cells [8], ecto-ADA has 
also been implicated in controling the extracellular concentra- 
tion of the nucleoside. ADA binds to the cell surface of T 
lymphocytes through the activation marker CD26 [9], which is 
also known as dipeptidylpeptidase IV or ADA binding protein. 
In this report, a close interaction between ADA and the A~ 
adenosine receptor (A~R) present on DDT~MF-2 cells is dem- 
onstrated by immunoprecipitation, confocal microscopy and 
affinity chromatography. Here we also provide evidence that 
the interaction ADA-A~R modulates ligand binding to A~R 
and signalling via A~R. 
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2. Experimental 
2.1. Materials 
[3H]R-N%(2-phenylisopropyl)-adenosine ([3H]R-PIA) (36 Ci/mmol), 
myo-[3H]inositol (85 Ci/mmol) and ECL immunoblotting detection sys- 
tem, were purchased from Amersham (Nuclear Iberica, Madrid, 
Spain). Adenosine deaminase (ADA, EC 3.5.4.4) from Sigma Chemical 
Co (St. Louis, MO, USA) was chromatographied through a Sephadex 
G-100 column and the final preparation was homogenous by electro- 
phoresis. Rabbit anti-ADA antibody (Serotec, Oxford, UK) has been 
developed in our laboratory [8]. Antibodies against A~ adenosine r cep- 
tors, PCI1 and PC12, are, respectively, affinity purified (chromato- 
graphied through specific peptide coupled to Sepharose) versions of 
antipeptide antisera PC10 and PC20 developed and characterized as 
described elsewhere [10]. The specificity of anti-A~R antibodies was 
tested as described elsewhere [10]. PC11 and PC21 were not able to 
recognize ADA from DDT~-MF2 cell extracts by immunoblotting (Fig. 
3B) and from a calf intestine commercial soluble preparation by im- 
munoprecipitation r immunoblotting. The antibody against CD26 
(H12 monoclonal) was purchased from Endogen Inc. DDT~MF-2 
smooth muscle cells from hamster vas deferens were obtained from and 
cultured as recomended by the American Type Culture Collection. 
2.2. Enzyme activities and ADA inhibition by Hg 2+ 
Adenosine deaminase (ADA, EC 4.5.4.4) and lactate dehydrogenase 
(EC 1.1.1.29) activities were estimated as described by Franco et al. [11] 
(in the presence of 1 pM dipyridamole and 1 pM nitrobenzylthioinosine 
as adenosine transport inhibitors). Dipeptidylpeptidase IV (CD26, EC 
3.4.14.5) activity was assayed as described by Nagatsu et al. [12]. Calf 
ADA activity (50 U/ml) was completely abolished after preincubation 
with 100/.tM HgC12 (2 h) and removal of free Hg 2+ by gel filtration using 
Sephadex G-25. 
2.3. Protein determination 
Protein was measured as described by Sorensen and Brodbeck [13]. 
2.4. Immunostaining experiments 
For confocal microscopy analysis, nonpermeabilized c lls were fixed 
(4% paraformaldehyde) for 15 min and washed in PBS-20 mM glycine. 
Double immunofluorescence staining was performed after 30 min incu- 
bation with PBS-20 mM glycine-l% bovine serum albumin (buffer B) 
by applying a mixture of antibodies (60 min, 37°C, buffer B): fluores- 
cein-conjugated rabbit anti-A~R (PC21, 100/lg/ml) and rhodamine- 
conjugated rabbit anti-ADA (40 pg/ml), or rhodamine-conjugated rab- 
bit anti-ADA (40 ~tg/ml) and fluorescein-conjugated anti-CD26 (20 
pg/ml), or rhodamine-conjugated PC21 (100 pg/ml) and fluorescein- 
conjugated anti-CD26 (20 pg/ml). Rinsed coverslips were mounted with 
immunofluorescence m dium. Observations were performed with a 
Leica TCS 4D confocal scanning laser microscope. 
Immunoprecipitation of AIR cross-linked to iodinated (R)-2-azido- 
N2-p-hydroxy-PIA(R-AHPIA), autoradiography and immunoblotting 
were performed as described by Ciruela et al. [10]. 
2.5. Radioligand binding assay 
Saturation analysis of [3H]R-PIA binding to membranes (0.7 mg/ml) 
was performed as previously described [14]. Experiments using intact 
cells (1.5 million/ml) were performed at 4°C for 4 h in serum-free 
DMEM buffered with 20 mM HEPES, pH 7.4. Saturation isotherms 
were obtained from five replicates for each [3H]R-PIA concentration (8 
in the range 0.01 200 nM) and were fitted by non-linear regression 
analysis. The F-test was used to discriminate b tween two affinity states 
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Fig. 1. Distribution of A~R, ADA and CD26 on the DDTIMF-2 cell surface. Nonpermeabilized cells were fixed (4% paraformaldehyde) for 15 min 
and washed in PBS-20 mM glycine. Double immunofluorescence staining was performed as indicated in section 2. Panel A. Vertical section of cells 
labeled for A1R (left) and ADA (right). Images are at the same scale than in panel B. Panel B. Surface xpression of AIR (upper left) and ADA (upper 
right). Panel C. Cell on glass coverslips were preincubated with 2 U/ml of exogenous ADA (30 min) before fixation (ADA from Sigma was 
chromatographed on Sephadex G-100; the final preparation was homogenous by electrophoresis). Surface expression of AIR (upper left) and ADA 
(upper ight). Panel D. Surface expression of CD26 (upper left) and ADA (upper ight). Panel E. Surface expression of CD26 (upper left) and AtR 
(upper ight). In B, C, D and E, the lower left image corresponds to the superposition of the two fluorescences (yellow) whereas the bottom right 
image shows colocalization i  white (insert: multi-color analysis of confocal images). Scale bar -- 10/tm. 
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and one affinity state. The two-site model was selected when P < 0.001 
[14]. 
2.6. Chromatography ( f A I adenosine receptor using an ADA affinity, 
column 
Solubilized extracts (2 mg protein/ml, 0.5% CHAPS, 0.5% digitonin 
in 50 mM Tris-HC1 buffer, pH 7.4) obtained from DDTjMF-2 cells 
were applied to a 1 ml of ADA-affinity column at a flow rate of 2.5 ml/h 
at room temperature. The ADA-affinity column was prepared by direct 
coupling of 10 mg of commercial calf intestinal adenosine deaminase 
(filtered through Sephadex G-25 and further purified to homogeneity 
by affinity chromatography) to a 1 g of cyanogen bromide-activated 
Sepharose. After the application, the column was cooled to 4°C and 
washed with 15 volumes of 50 mM Tris-HC1, 0.1% CHAPS, 0.1% 
digitonin, pH 7.4, until no protein was detected in the eluates. All 
fractions were assayed for [3H]R-PIA binding, lactate dehydrogenase 
activity and protein. 
2.7. Second messengers determination 
Ca 2+ release from intracellular stores and the level of inositol phos- 
phates (InsP) were measured as described elsewhere [15-17]. In cells 
(106 cells/ml) loaded with the fluorescent dye Fura 2-AM (5/~M, 30 
min), the 50 nM R-PIA-induced Ca 2+ mobilization, was determined in
a dual-wavelength fluorimeter by using the ratio of excitation wave- 
lengths 334/366 nm with emission cut off at 500 nm. For inositol 
phosphates determination, inositol-starved cells (0.5 million/ml) were 
incubated with DMEM containing myo[3H]inositol (5 ¢tCi/ml) for 40- 
48 h. After addition of 10 mM LiCI (10 min), inositol phosphate pro- 
duction was induced (15 min) by 50 nM R-PIA. Cells were treated with 
perchloric acid and total [3H]InsP was isolated using a Dowex AGI-X8 
column. 
3. Results and discussion 
DDT~MF-2 cells exhibit ecto-ADA. When 60 ¢tM adenosine 
was used as substrate, ecto-ADA activity (see section 2) was 1.0 
mU per million of intact cells. DDT~ MF-2 cells also express on 
their surface binding sites for the A~ adenosine receptor specific 
agonist [3H]R-PIA (see Table 1). These cells therefore provide 
a unique model to study potential interactions between the 
receptor for a ligand (adenosine) and the ecto-enzyme r sponsi- 
s .  
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Fig. 2. Chromatography of cell extracts through an ADA-Sepharose 
column. The 1 nM [3H]R-PIA binding to A~ adenosine receptors and 
the lactate dehydrogenase activity was determined in the different frac- 
tions: not retained (dotted), wash (white) and retained (black). Values 
are given in percentage r spect to the total amount applied: 4 pmol for 
A~ adenosine receptors and 0.36 ,umol/min for lactate dehydrogenase 
activity. 
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Fig. 3. Immunochemical detection of A~R and ADA. Panel A. Copre- 
cipitation of ADA using antibodies against A~R. DDT~ M F-2 cell mem- 
branes were solubilized using 1% Nonidet-P40; immunoprecipitation 
using PC11 and PC12 (or anti-ADA and irrelevant IgG as controls) (40 
,ug/ml of each antibody) and immunoblotting (PVDF membranes) were 
performed as indicated in section 2. PVDF membranes were treated 
with anti-ADA antibody (5 yg/ml) and immunoreactive bands were 
visualized by horseradish-peroxidase-labelled goat anti-rabbit IgG an- 
tibodies (1:15000-fold ilution), followed by ECL chemiluminiscence 
detection. Arrow: ADA Arrow head: IgG heavy chain. Panel B. A~R 
recognition by PCll and PC21. Immunoprecipitation f A~R cross- 
linked to iodinated (R)-2-azido-N2-p-hydroxy-PIA (R-AHPIA) (left 
image). Labelled membranes (0.5 mg protein/ml) were immunoprecipi- 
tared in the absence or in the presence of 40~tg/ml of either PCI 1, PC21 
or an irrelevant IgG. lmmunoprecipitated material was analyzed by 
SDS- PAGE. The gel was run, dried and autoradiographed. Im- 
munoblotting of A~R using PC 11 and PC21 antibodies (right image). 
In DDT~MF-2 cells the 74 kDa band that PC21 recognizes in pig brain 
membranes [10], was not detected. 
ble for ligand degradation. As judged by cell surface im- 
munofluorescence staining with rhodamine isothiocyanate- 
conjugated anti -ADA and fluorescein isothiocyanate-conju- 
gated anti-AiR, the cell surface distributions of ADA (red flu- 
orescence) and A~R (green fluorescence) on the surface of 
DDT~MF-2 cells appeared similar (Fig. IA,B). The label was 
indeed corresponding to a cell surface staining as judged by the 
lack of intracellular stain (Fig. 1A). Further analysis by confo- 
cal microscopy demonstrated that the degree of colocalization 
between ADA and AIR on the surface of DDTIMF-2  cells was 
very high. The intensity of white and its situation far from the 
axis origin of the cytofluorogram indicated that the colocaliza- 
tion was quantitatively very high (Fig. 1 B, insert of the bottom 
right image). Since DDT~MF-2 cells also express CD26 on their 
surface (dipeptidylpeptidase activity using 1 mM gly-pro-par- 
anitroanilide as substrate was 3.4 mU per million cells), the 
codistribution of ADA (red fluorescence) and CD26 (green 
fluorescence) (Fig. 1 D) and of CD26 (green fluorescence) and 
AtR (red fluorescence) (Fig. 1E) were studied. In contrast to 
the codistribution of ADA and AIR, ADA and CD26 or A~R 
and CD26 had a different distribution pattern with a moderate 
degree of colocalization (in white). Taken together, these colo- 
calization studies suggested that there were significantly more 
ADA molecules colocalizing with A1R than with CD26; there- 
fore, A~R may act as a second receptor for ecto-ADA. 
Next we examined whether exogenous ADA could bind to 
cell surface A~R molecules that did not colocalize with en- 
dogenous ADA,  i.e. those labelled green in the images of Fig. 
lB. Indeed, addition of exogenous ADA led to the complete 
disappearance of the green fluorescence and to an increase in 
white in the confocal images, which indicated increased colocal- 
ization (Fig. 1C). Thus, all AIR molecules present on the sur- 
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Fig. 4. R-PIA-induced calcium mobilization and total [3H]InsP produc- 
tion in DDTIMF-2 cells. 50 nM R-PIA induced calcium mobilization 
(A) and inositol phosphates production (15 min) (B). Cells were incu- 
bated (30 min) in the absence (-ADA) or presence of 0.2 U/ml of 
adenosine deaminase, nzymatically active (+ADA) or irreversibly in- 
hibited by 100 #M HgCI: (2 h, room temperature) and desalted through 
a Sephadex G-25 (+ADA-Hg2+). 
face of DDT~MF-2 cells can bind ADA. We conclude that an 
interaction ADA-AtR occurs at the cell surface level in intact 
cells. 
The ability of ADA to recognize A~R was confirmed by 
isolating the A1R from a detergent extract (obtained as de- 
scribed in section 2) with an ADA-Sepharose affinity column. 
A~R was 67% retained within the column whereas a control 
protein, lactate dehydrogenase, was completely eluted (Fig. 2). 
Conversely, ADA was coprecipitated from membrane xtracts 
using two (PC11 and PC21) different antipeptide anti-A~R an- 
tibodies (Fig. 3A). Both antibodies immunoprecipitated A~R 
photolabelled with [125I]R-PIA (with an efficiency that ranges 
from 15 to 25% [10]) and both recognized the 39 kDa band of 
the receptor by Western blotting (Fig. 3B). However, PCI 1 was 
more effective in immunoprecipitation a d Western blotting 
experiments than PC21. For this reason the coprecipitated 
ADA band was stronger when PC11 was used (Fig. 3A). These 
results support he notion that A1R binds ADA on the surface 
of DDT~MF-2 cells. 
Because ADA and A1R interacted on the surface of 
DDTIMF-2 cells, the influence of ADA on the thermodynamic 
behavior of the agonist [3H]R-PIA binding to A~R was ana- 
lyzed. Addition of ADA reportedly results in an increase in 
[3H]R-PIA binding to A1R as a consequence of the degradation 
of endogenous adenosine [18,19]. The effect of exogenous ADA 
on [3H]R-PIA binding to intact DDT~MF-2 cells and to mem- 
branes from these cells was analyzed. AIR in intact cells dis- 
played, in the absence of external ADA, a very low affinity state 
(Kd = 40 nM) similar to that found in membrane preparations 
(Table 1). In the presence of exogenous ADA the affinity for 
[3H]R-PIA increased significantly (Kd = 10 nM). The effect of 
ADA in membranes was more pronounced since it converted 
the single very-low affinity state o fA ,R  (Kd = 50 nM) into two 
states (one of high affinity, 0.79 nM, and another of low affin- 
ity, 8.7 nM). The complete blockade of deaminase activity, by 
preincubating ADA with Hg >, did not produce any significant 
changes in the K d and Bma X values obtained in the presence of 
ADA (Table 1). On the other hand, endogenous adenosine did 
not affect [3H]R-PIA binding to A~R. First, the concentration 
of adenosine in the binding assays to membranes was very low 
(2540 nM detected by HPLC). Second, IC50 values for ade- 
nosine as displacer of [3H]R-PIA binding to membranes in 
presence of Hg2+-inhibited ADA were very high: 129 #M (high- 
Table 1 
Equilibrium parameters of [3H]R-PIA binding to DDT~MF-2 cells and to cell membranes in the absence or presence of ADA 
Presence of ADA Affinity-state K d (nM) Bma X (pmol/mg prot.) 
Membranes None High-affinity 
Low-affinity 
Very low-affinity 50 + 10 0.4 + 0.1 
0.2 U/ml High-affinity 0.79 _+ 0.09 0.28 + 0.03 
Low-affinity 8.7 + 1.6 0.15 + 0.05 
Very low-affinity 
*0.2 U/ml High-affinity 1.5 + 0.5 0.25 + 0.05 
plus Hg 2+ Low-affinity 9 +_ 2 0.13 _+ 0.07 
Very low-affinity 
Intact cells None 
0.2 U/ml 
High-affinity 
Low-affinity 
Very low-affinity 40 + 10 0.10 + 0.03 
High-affinity 
Low-affinity 10 + 6 0.11 + 0.02 
Very low-affinity 
*0.2 U/ml High-affinity 
plus Hg 2+ Low-affinity 10 + 3 0.15 _+ 0.02 
Very low-affinity 
*ADA in 50 mM Tris-HC1 buffer, pH 7.4, was incubated for 2 h with 100 pM HgCI 2. Free Hg 2÷ was eliminated by gel filtration using Sephadex 
G-25. The eluted protein (HgZ+-ADA) was devoid of deaminase activity. 
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affinity) and 2.7 mM (low-affinity). Thus, this alteration in the 
behavior of membrane A1R in the presence of ADA is not due 
to the degradation of the endogenous ligand, adenosine, but to 
a direct effect upon AtR. 
Does ADA induce signal transduction events via A~R? To 
address this, DDTIMF-2 cells were treated with R-PIA with or 
without ADA (or Hg2+-inhibited ADA) and the release of Ca 2+ 
from intracellular stores and the level of inositol phosphates 
(InsP) were measured. As shown in Fig. 4A, the R-PIA-induced 
increase in intracellular Ca 2+ in the presence of exogenous 
ADA was five-fold higher than in the absence of the enzyme. 
ADA by itself did not modify the level of these second messen- 
gers. In some experiments the effect of R-PIA upon Ca 2÷ mobi- 
lization was evident only in the presence of exogenous ADA. 
The increase in inositol phosphates was also amplified by exter- 
nal ADA (Fig. 4B). Induction of both second messengers was 
independent of the catalytic activity of the enzyme since a 
similar potentiation was obtained by Hg2+-inhibited ADA. 
Thus, ADA is necessary for an efficient coupling of A~R with 
the signal tranduction machinery. Signalling in the absence of 
ADA may be due to a small proportion of AIR molecules 
interacting with endogenous ADA. It should be noted that 
signalling via A~ adenosine receptors has been always investi- 
gated in the present of exogenous ADA. This practice used in 
principle to eliminate the endogenous ligand, adenosine, has 
lead to believe that exogenous ADA had no effect on ligand- 
induced signalling. However, as evidenced here, ecto-ADA has 
a key role in A,R functioning. 
Taking into account hat the changes of affinity in the case 
of A~R reportedly reflect changes in the coupling to hetero- 
trimeric G proteins, we postulate that ADA is required for 
coupling of the A~R to heterotrimeric G proteins in DDTIMF- 
2 cells. This is tile first report providing evidence that a heptas- 
panning receptor equires a cell surface protein for efficient 
signalling. Modulation of A~R-mediated signal transduction by 
ADA-A~R interaction opens a new perspective in the regula- 
tion mechanism of heptaspanning receptors coupled to G pro- 
teins. 
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